PAP
STRO icon

Persistent Asset Partners’s Sutro Biopharma STRO Stock Holding History

Persistent Asset Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
+7,411
New +$134K 0.07% 203

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Persistent Asset Partners's STRO Position: Q1 2026 in Review

Persistent Asset Partners opened a new position in Sutro Biopharma (STRO) in Q1 2026: 7,411 shares worth $185K. The stake represents 0.07% of the portfolio and ranks #203 among its holdings.

78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Persistent Asset Partners held 7,411 shares of Sutro Biopharma worth $185K as of Q1 2026.
  • Sutro Biopharma was a new Persistent Asset Partners position in Q1 2026.
  • Sutro Biopharma made up 0.07% of Persistent Asset Partners's portfolio in Q1 2026, its #203 holding.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.